Strides Pharma Science Ltd Q1FY23 consolidated loss at Rs. 135.89 crores

Strides Pharma Science Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 953.622 crores during the period ended June 30, 2022 as compared to Rs. 952.075 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. -135.892 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 29.219 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. -15.13 for the period ended June 30, 2022 as compared to Rs. 3.25 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹953.622 crs	₹952.075 crs	0.16%
Net Profit	₹-135.892 crs	₹29.219 crs	-565.08%
EPS	₹-15.13	₹3.25	-565.54%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs.953.622 crores during the period ended June 30, 2022 as compared to Rs.701.898 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.-135.892 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.-205.20 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.-15.13 for the period ended June 30, 2022 as compared to Rs.-22.88 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹953.622 crs	₹701.898 crs	35.86%
Net Profit	₹-135.892 crs	₹-205.20 crs	33.78%
EPS	₹-15.13	₹-22.88	33.87%

Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 334.20 as compared to the previous close of Rs. 338.00. The total number of shares traded during the day was 15534 in over 1300 trades.

The stock hit an intraday high of Rs. 344.15 and intraday low of 332.70. The net turnover during the day was Rs. 5224990.00.

Source : Equity Bulls

Keywords

StridesPharmaScience Q1FY23 ResultUpdate